ריבוי פוליפים בחולה צעיר. איתי מזאה MD PhD

Similar documents
COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

Genetic Aspects of Inherited colorectal cancer (CRC)

NGS for Cancer Predisposition

The Next Generation of Hereditary Cancer Testing

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

Genetic Risk Assessment for Cancer

Myriad Financial Assistance Program (MFAP)

Learn your genetic risk for the most common hereditary cancers.

Genetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017

Hereditary Gastric Cancer

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Genetic testing all you need to know

A guide to genetic testing for hereditary cancers

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION

Germline Multigene Panel Testing in Oncology: Genetic Counseling Perspective

Clinical Cancer Genetics

Genetic Testing for Lynch Syndrome

Prior Authorization. Additional Information:

Management of higher risk of colorectal cancer. Huw Thomas

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital


Hereditary Cancer Update: What do GPOs need to know?

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing

Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD

Corporate Medical Policy

Prior Authorization. Additional Information:

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

10/21/ New Release, Quest Diagnostics Nichols Institute, Valencia

Accepted Manuscript. Utility of Genetic Testing in Persons with Multiple Colorectal Polyps. Natalia Khalaf, MD, MPH, Niloy Jewel Samadder, MD, MS

GEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T. Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics

Populations Interventions Comparators Outcomes Individuals: With a personal and/or family history suggesting an inherited cancer syndrome

Medical Policy Update

Genetic testing and pancreatic disease

Cancer Genomics 101. BCCCP 2015 Annual Meeting

Objectives. Genetics in Cancer Treatment and Prevention. Genes

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Genetic Testing for Hereditary Cancer Susceptibility Syndromes

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

Hereditary Cancer Risk Assessment for Gynecological Cancers. FarrNezhatMD.com

MSI positive MSI negative

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

Genetic Risk Assessment for Cancer

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013

Genetic testing for hereditary cancer

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing

Hereditary Cancer Products

Germline Testing for Hereditary Cancer with Multigene Panel

patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

CANCER GENETICS PROVIDER SURVEY

Genetic Testing: who, what, why?

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY. Name of Test Turnaround Time Cost CPT codes

Pathology reports, related operative reports and consult letters must be provided with a request for assessment.

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

Hereditary GI tumor syndromes ACG guidelines of genetic testing and management. Dr. med. Henrik Csaba Horváth PhD

The Role of genetic Testing for Inherited Prostate Cancer Risk

HEREDITY & CANCER: Breast cancer as a model

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY

Hereditary Aspects of Colorectal Cancer

BRCAplus. genetic testing for hereditary breast cancer

GI EMERGENCIES Acute Abdominal Pain

Robert Nathan Slotnick MD PhD FACOG FACMG (FF) Perinatologist and Director Medical Genetics

11/29/2017. Genetics and Cancer ERICA L SILVER, MS, LCGC GENETIC COUNSELOR. Genetics 101. Transcription vs Translation

Why Test for Hereditary Cancer in Preventive Care?

Carol Christianson, MS, CGC Genetic Counselor West Michigan Cancer Center

Inherited colon cancer and other inherited cancer predispositions. Dr Anne De Leener Centre de Génétique Humaine

Genetics and Cancer Care. Cynthia Forster-Gibson, MD, PhD and Loren Mackay- Loder, MSc Genetics Program, THP

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer

Use of panel tests in place of single gene tests in the cancer genetics clinic

Multigene Panel Testing for Hereditary Cancer Risk

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Colorectal Cancer Syndromes. Barbara Jung, MD AGAF Associate Professor and Chief University of Illinois at Chicago

Genetic Determinants, Risk Assessment and Management

Update on Hereditary Gastric Cancer. Dr. Savtaj Brar MD MSc Surgical Oncologist Assistant Professor of Surgery

CASE STUDY. Germline Cancer Testing in A Proband: Extension of Benefits to Unaffected Family Members. Introduction. Patient Profile.

Familial and Hereditary Colon Cancer

Familial Adenomatous Polyposis

Are you at risk of Hereditary Cancer? Your Guide to the Answers

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR INHERITED SUSCEPTIBILITY TO COLORECTAL CANCER. POLICY NUMBER: CATEGORY: Laboratory Test

Pathology perspective of colonic polyposis syndromes

Familial and Hereditary Colon Cancer

Ovarian Cancer Causes, Risk Factors, and Prevention

OncoGeneDx Test Requisition Form

The Role of the Surgical Pathologist in the Diagnosis of Rare Polyposis Syndromes 1. Lynch Syndrome

Insights. Genetic/Familial High-Risk Assessment: Colorectal, Version

PROVIDER POLICIES & PROCEDURES

Molecular Biomarkers in the Characterization & Treatment of Colorectal Carcinoma

Transcription:

ריבוי פוליפים בחולה צעיר איתי מזאה MD PhD

הצגת מקרה בן 44, מוצא אשכנזי ללא מחלות רקע לא נוטל תרופות קבועות

הצגת מקרה 12/2014 הופעת דמם רקטלי קולונוסקופיה: 4 פוליפים הגדול 2 ס"מ TVA TA שני פוליפים היפרפלסטיים

הצגת מקרה 03/2015 קולונוסקופיה חוזרת פוליפ שטוח 5 ס"מ בצקום, הורד בחלקים פתולוגיה TVA עוד שני פוליפים קטנים היפרפלסטיים

סיכום ביניים פוליפים גדולים מסוג TVA פוליפים היפרפלסטיים בן 44 סה"כ: 2 4

What NEXT?

בירור גנטי 3 מוטציות שכיחות בגנים MSH2/MSH6 שליליות מוטציות ב- MUTYH שליליות מה הלאה?

Next Generation Sequencing (Panels)

Gene RefSeq Disease Association or Cancer Risk Complete Sequencing Del/Dup Added RPS20 NM_001023.3 Colon cancer Yes Yes February 2015 MLH1 NM_000249.3 Lynch, Muir-Torre Yes Yes November 2011 MSH2, includes exon 1-7 NM_000251.1 Lynch, Muir-Torre Yes Yes November 2011 inversion MSH6 NM_000179.2 Lynch Yes Yes November 2011 PMS2 NM_000535.5 Lynch Yes Yes November 2011 EPCAM NM_002354.2 Lynch Yes Yes November 2011 APC NM_000038.5 FAP, Turcot Yes Yes November 2011 MUTYH NM_001128425.1 MUTYH-associated Yes Yes November 2011 polyposis CDH1 NM_004360.3 Hereditary diffuse gastric Yes Yes June 2012 cancer CTNNA1 NM_0011903.2 Hereditary diffuse gastric Yes Yes October 2014 cancer PTEN NM_000314.4 Cowden Yes Yes June 2012 AKT1 NM_005163.2 Cowden-like, Breast, thyroid cancers, macrocephaly Yes Yes October 2013 PIK3CA NM_006218.2 Cowden-like, Breast, thyroid cancer, macrocephaly Yes Yes October 2013 STK11 NM_000455.4 Peutz-Jeghers Yes Yes June 2012 TP53 NM_000546.5 Li-Fraumeni Yes Yes June 2012 CHEK2 NM_007194.3 Li-Fraumeni-like Yes Yes February 2015 SMAD4 NM_005359.5 Juvenile Polyposis Yes YES January 2013 BMPR1A NM_004329.2 Juvenile Polyposis Yes Yes January 2013 POLE NM_006231.2 Colon cancer Yes Yes October 2013 POLD1 NM_002691.3 Colon cancer Yes Yes October 2013 GALNT12 NM_024642.4 Colon cancer Yes Yes October 2013 GREM1 NM_001191323.1 Polyposis Yes Yes October 2013 AXIN2 NM_004655.3 Colon cancer, oligodontia Yes Yes February 2015

Gene RefSeq Disease Association or Cancer Risk Complete Sequencing Del/Dup Added RPS20 NM_001023.3 Colon cancer Yes Yes February 2015 MLH1 NM_000249.3 Lynch, Muir-Torre Yes Yes November 2011 MSH2, includes exon 1-7 NM_000251.1 Lynch, Muir-Torre Yes Yes November 2011 inversion MSH6 NM_000179.2 Lynch Yes Yes November 2011 PMS2 NM_000535.5 Lynch Yes Yes November 2011 EPCAM NM_002354.2 Lynch Yes Yes November 2011 APC NM_000038.5 FAP, Turcot Yes Yes November 2011 MUTYH NM_001128425.1 MUTYH-associated Yes Yes November 2011 polyposis CDH1 NM_004360.3 Hereditary diffuse gastric Yes Yes June 2012 cancer CTNNA1 NM_0011903.2 Hereditary diffuse gastric Yes Yes October 2014 cancer PTEN NM_000314.4 Cowden Yes Yes June 2012 AKT1 NM_005163.2 Cowden-like, Breast, thyroid cancers, macrocephaly Yes Yes October 2013 PIK3CA NM_006218.2 Cowden-like, Breast, thyroid cancer, macrocephaly Yes Yes October 2013 STK11 NM_000455.4 Peutz-Jeghers Yes Yes June 2012 TP53 NM_000546.5 Li-Fraumeni Yes Yes June 2012 CHEK2 NM_007194.3 Li-Fraumeni-like Yes Yes February 2015 SMAD4 NM_005359.5 Juvenile Polyposis Yes YES January 2013 BMPR1A NM_004329.2 Juvenile Polyposis Yes Yes January 2013 POLE NM_006231.2 Colon cancer Yes Yes October 2013 POLD1 NM_002691.3 Colon cancer Yes Yes October 2013 GALNT12 NM_024642.4 Colon cancer Yes Yes October 2013 GREM1 NM_001191323.1 Polyposis Yes Yes October 2013 AXIN2 NM_004655.3 Colon cancer, oligodontia Yes Yes February 2015

נמצאה מוטציה GREM1 בגן Hereditary Mixed Polyposis Syndrome תורשה אוטוזומלית דומיננטית פוליפים עם היסטולוגיה מעורבת: היפרפלסטיים אדנומטוטיים JUVENILE עליה בשכיחות של CRC

2012

Hereditary Mixed Polyposis Syndrome o 3 Jewish Ashkenazi families with HMPS o Dominant inheritance

סיכום Hereditary mixed polyposis syndrome may be caused by a mutation upstream to the GREM1 gene Dominant inheritance Ashkenazi Jews Rising role of genetic panels

תודה רבה